Risk factor | Number tested | Malaria in second year n. % | OR 95% CI | Wald test P-value | Area under the ROC curve |
---|---|---|---|---|---|
PCR individual infection in baseline survey* | Â | Â | Â | Â | Â |
Neg | 1,763 | 827 [46.9] | 1 | <0.001 | 0.560 |
Pos | 905 | 521 [57.6] | 1.58 [1.31-1.83] | Â | Â |
PCR prevalence | Â | Â | Â | Â | Â |
Satscan exposure category | 792 | 319 [40.3] | 1 | 0.181 | 0.620 |
coldspot | 1,728 | 864 [50.0] | 1.35 [0.87-2.09] | <0.001 | 0.628 |
neither | 726 | 500 [68.9] | 4.54 [2.68-7.72] | 0.966 | 0.597 |
hotspot | 804 | 390 [48.5] | 1 | 0.013 | Â |
Kernel exposure quartiles | 819 | 387 [47.2] | 0.99 [0.60-1.64] | <0.001 | Â |
<14.9 | 818 | 331 [40.5] | 0.53 [0.32-0.88] | 0.165 | Â |
15-21.3 | 805 | 575 [71.4] | 3.45 [2.06-5.75] | 0.042 | Â |
21.4-27.1 | 816 | 420 [51.5] | 1 | 0.003 | Â |
>27.1 | 794 | 344 [43.3] | 0.69 [0.41-1.16] | Â | Â |
Weighted exposure quartiles | 807 | 372 [46.1] | 0.58 [0.35-0.98] | Â | Â |
<18.9 | 799 | 520 [65.1] | 2.21 [1.31-3.73] | Â | Â |
19-23.2 | Â | Â | Â | Â | Â |
23.3-26.5 | Â | Â | Â | Â | Â |
>26.5 | Â | Â | Â | Â | Â |
AMA-1 individual prevalence | Â | Â | Â | Â | Â |
No | 1,262 | 594 [47.1] | 1 | <0.001 | 0.554 |
Yes | 1,071 | 593 [55.4] | 1.45 [1.21-1.72] | Â | Â |
AMA-1 prevalence | Â | Â | Â | Â | Â |
Satscan exposure category | 904 | 310 [34.3] | 1 | <0.001 | 0.647 |
coldspot | 1,092 | 554 [50.7] | 2.65 [1.69-4.15] | <0.001 | 0.618 |
neither | 1,250 | 819 [65.5] | 5.84 [3.75-9.10] | 0.002 | 0.609 |
hotspot | 814 | 308 [37.8] | 1 | <0.001 | Â |
Kernel exposure quartiles | 813 | 414 [50.9] | 2.26 [1.35-3.79] | <0.001 | Â |
<27.9 | 812 | 425 [52.3] | 2.62 [1.57-4.39] | 0.154 | Â |
28-38.9 | 807 | 536 [66.4] | 5.16 [3.06-8.69] | <0.001 | Â |
39-53.0 | 804 | 325 [40.4] | 1 | <0.001 | Â |
>53.0 | 809 | 357 [44.1] | 1.45 [0.86-2.44] | Â | Â |
Weighted exposure quartiles | 800 | 476 [59.5] | 3.50 [2.07-5.91] | Â | Â |
<18.9 | 803 | 498 [62.0] | 3.33 [1.97-5.62] | Â | Â |
19-23.9 | Â | Â | Â | Â | Â |
24 -26.9 | Â | Â | Â | Â | Â |
>26.9 | Â | Â | Â | Â | Â |
MSP-1 19 individual prevalence | Â | Â | Â | Â | Â |
No | 1,730 | 924 [53.4] | 1 | 0.196 | 0.541 |
Yes | 681 | 341 [50.1] | 0.88 [0.73-1.06] | Â | Â |
MSP prevalence | Â | Â | Â | Â | Â |
Satscan exposure category | 1,703 | 992 [58.2] | 1 | 0.040 | 0.591 |
coldspot | 967 | 493 [51.0] | 0.64 [0.41-0.98] | <0.001 | 0.622 |
neither | 576 | 198 [34.0] | 0.21 [0.13-0.34] | 0.773 | 0.625 |
hotspot | 806 | 418 [51.9] | 1 | 0.008 | 0.631 |
Kernel exposure quartiles | 835 | 440 [52.7] | 1.08 [0.65-1.78] | <0.001 | Â |
<12.9 | 808 | 538 [66.6] | 2.02 [1.21-3.38] | 0.715 | Â |
13-17.3 | 797 | 287 [36.0] | 0.34 [0.20-0.55] | 0.006 | Â |
17.4-25.4 | 805 | 415 [51.6] | 1 | <0.001 | Â |
>25.4 | 813 | 430 [52.9] | 1.10 [0.66-1.81] | Â | Â |
Weighted exposure quartiles | 802 | 533 [66.5] | 2.08 [1.23-3.51] | Â | Â |
<16.5 | 796 | 278 [34.9] | 0.35 [0.21-0.57] | Â | Â |
16.6-18.3 | Â | Â | Â | Â | Â |
18.4-22.7 | Â | Â | Â | Â | Â |
>22.7 | Â | Â | Â | Â | Â |
MSP-1 19 &/ or AMA - 1 individual prevalence | Â | Â | Â | Â | Â |
No | 986 | 253 [25.6] | 1 | 0.986 | 0.530 |
Yes | 1,237 | 466 [37.7] | 1.00 [0.78-1.29] | Â | Â |
MSP-1 19 &/or AMA-1 prevalence | Â | Â | Â | Â | Â |
Satscan exposure category | - | 400 [48.4] | - | - | - |
coldspot | - | 357 [44.6] | - | - | 0.604 |
neither | - | 386 [47.0] | - | - | 0.530 |
hotspot | 827 | 540 [67.8] | 1 | 0.082 | Â |
Kernel exposure quartiles | 800 | 402 [49.3] | 0.63 [0.37 - 1.07] | 0.310 | Â |
<44.5 | 822 | 380 [47.4] | 0.77 [0.46-1.28] | 0.001 | Â |
44.6-51.4 | 797 | 372 [45.6] | 2.44 [1.44-4.14] | 0.507 | Â |
51.5-59.3 | 816 | 502 [64.0] | 1 | 0.063 | Â |
>59.4 | 801 | Â | 0.84 [0.49-1.42] | 0.023 | Â |
Weighted exposure quartiles | 815 | Â | 0.60 [0.36-1.03] | Â | Â |
<16.5 | 784 | Â | 1.86 [1.09-3.18] | Â | Â |
16.6-18.3 | Â | Â | Â | Â | Â |
18.4-22.7 | Â | Â | Â | Â | Â |
>22.7 | Â | Â | Â | Â | Â |